Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III, in patients with advanced solid malignancies - Hammond-Thelin, Lisa A.; Thomas, Melanie B.; Iwasaki, Michiko; Abbruzzese, James L.; Lassere, Yvonne; Meyers, Christina A.; Hoff, Paulo; Bono, Johann de; Norris, Jody; Matsushita, Hitoshi; Mita, Akira; Rowinsky, Eric K. (Investigational New Drugs, 2012)